Exabis Library
Welcome to the e-CCO Library!
P624: Vedolizumab can induce clinical remission in patients with chronic antibiotic-refractory pouchitis: A retrospective single-centre experience
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P625 Kinetics and outcomes of transmural healing in patients with Crohn’s disease treated with anti-TNF therapy 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P625: A prospective study to assess the effectiveness of tacrolimus therapy in ulcerative colitis
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P625: Characteristics of SARS-CoV-2 infection in IBD patients in the second and third wave compared with the first wave and with the data of general population
 2021
 ECCO'21 Virtual
 Wednesday, 2 June 2021, 4:12 PM
P625: Head-to-head comparison of three stool calprotectin tests for home use 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P625: Predictors of pancreatitis among patients with inflammatory bowel disease (IBD) treated with vedolizumab (VDZ): Observation from a large global safety database
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P625: Randomized controlled trial on the effect of megaboluses of intravenous corticosteroids added to oral corticosteroids in the treatment of moderately active ulcerative colitis
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:05 AM
P625: Ustekinumab use in Crohn's disease: effectiveness of dose escalation
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P626 Patients with IBD seek extra supportive care: insights from Israeli social media networks 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P626: Anti-TNF monotherapy is associated with an adverse clinical outcome in female Inflammatory Bowel Disease patients who stop Anti-TNF treatment during the third trimester of pregnancy.
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P626: Development of a model of 3D imaging for the pre-operative planning of TaTME
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P626: Higher discontinuation rates of anti-TNF therapy in elderly IBD patients compared with a younger age group: results from a prospective registry 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P626: Safety of recombinant zoster vaccine in patients with Inflammatory Bowel Disease: a single centre experience
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:05 AM
P626: SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease
 2021
 ECCO'21 Virtual
 Wednesday, 2 June 2021, 4:12 PM
P626: Ustekinumab for the treatment of perianal fistulas in patients with Crohn's disease
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P627 Acute severe ulcerative colitis in pregnancy: A retrospective cohort study 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P627: Audit of the assessment, prevalence and treatment of osteoporosis in a single-centre cohort of patients with inflammatory bowel disease managed with tumour necrosis factor inhibitor treatment
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P627: Change in urgency among ulcerative colitis patients: Analyses from the SPARC IBD
 2021
 ECCO'21 Virtual
 Wednesday, 2 June 2021, 4:12 PM
P627: HLA DQA1*05 was not associated to primary non-response or loss of response to first anti-TNF in real world Inflammatory Bowel Disease patients.
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:05 AM
P627: Stopping anti-tumour necrosis factor (TNF) therapy in patients with perianal Crohn’s disease: Results from a population-based study 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM